State of the art and new developments in molecular diagnostics for hemoglobinopathies in multiethnic societies

International Journal of Laboratory Hematology

Volumn 36, Issue 1, 2014, Pages 1-12

  Harteveld, C L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hemoglobinopathy; Microarray technology; MLPA; Molecular diagnostics; Sickle cell disease; Thalassemia

Indexed keywords

HEMOGLOBIN A; HEMOGLOBIN A2; HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN F; HEMOGLOBIN S; HEMOGLOBIN VARIANT; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; PRIMER DNA;

ALPHA THALASSEMIA; BETA THALASSEMIA; BLOOD CELL COUNT; CAPILLARY ELECTROPHORESIS; COMPARATIVE GENOMIC HYBRIDIZATION; ETHNICITY; GENE CLUSTER; GENE DELETION; GENE DUPLICATION; GENOTYPE; GLOBIN GENE; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTICS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEQUENCE ANALYSIS; SICKLE CELL ANEMIA; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; DEVICES; DNA MICROARRAY; FEMALE; GENETIC COUNSELING; GENETICS; MALE; MOLECULAR PATHOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; PATHOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; TRENDS;

ALPHA-GLOBINS; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; BETA-GLOBINS; BETA-THALASSEMIA; DNA PRIMERS; FEMALE; GENETIC COUNSELING; HEMOGLOBINS, ABNORMAL; HUMANS; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATHOLOGY, MOLECULAR; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84892480312     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12108     Document Type: Review

References (36)

1. Weatherall DJ, Clegg JB. The Thalassemia Syndromes, 4th edn. Oxford, UK: Blackwell Science Ltd, 2001.
2. Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management, 2nd edn. New York: Cambridge University Press; 2009.
3. Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of Hemoglobin. Genetics, Pathophysiology and Clinical Management, 2nd edn. New York: Cambridge University Press; 2001.
4. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001;79: 704-12.
5. Weatherall DJ. The global problem of genetic disease. Ann Hum Biol 2005;32: 117-22.
6. Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, Gulbis B, Hopmeier P, Lena-Russo D, Romao L, Theodorsson E. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007;67:39-69.
7. Giordano PC. Strategies for basic laboratory diagnostics of the hemoglobinopathies in multi-ethnic societies: interpretation of results and pitfalls. Int J Lab Hematol 2012;doi:10.1111/ijlh.12037.
8. Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, Roper D, Rees DC, de la Salle B, Streetly A. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 2010;149: 35-49.
9. Recommendations for preconceptional or antenatal screening, prenatal diagnosis and genetic counselling of haemoglobinopathies (http://www.enerca.org). 2013.
10. UK NHS Sickle Cell and thalassaemia handbook for laboratories. (http://sct.screening.nhs.uk/standardsandguidelines). 2013.
11. Bauer DE, Kamran SC, Orkin SH. Reawakening fetal hemoglobin: prospects for new therapies for the beta-globin disorders. Blood 2012;120:2945-53.
12. Sankaran VG. Targeted therapeutic strategies for fetal hemoglobin induction. Hematology Am Soc Hematol Educ Program 2011;2011:459-65.
13. Xu J, Peng C, Sankaran VG, Shao Z, Esrick EB, Chong BG, Ippolito GC, Fujiwara Y, Ebert BL, Tucker PW, Orkin SH. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 2011;334:993-6.
14. Giardine B, van BS, Kaimakis P, Riemer C, Miller W, Samara M, Kollia P, Anagnou NP, Chui DH, Wajcman H, Hardison RC, Patrinos GP. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat 2007;28:206.
15. Giardine B, Borg J, Higgs DR, Peterson KR, Philipsen S, Maglott D, Singleton BK, Anstee DJ, Basak AN, Clark B, Costa FC, Faustino P, Fedosyuk H, Felice AE, Francina A, Galanello R, Gallivan MV, Georgitsi M, Gibbons RJ, Giordano PC, Harteveld CL, Hoyer JD, Jarvis M, Joly P, Kanavakis E, Kollia P, Menzel S, Miller W, Moradkhani K, Old J, Papachatzopoulou A, Papadakis MN, Papadopoulos P, Pavlovic S, Perseu L, Radmilovic M, Riemer C, Satta S, Schrijver I, Stojiljkovic M, Thein SL, Traeger-Synodinos J, Tully R, Wada T, Waye JS, Wiemann C, Zukic B, Chui DH, Wajcman H, Hardison RC, Patrinos GP. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet 2011;43:295-301.
16. van Delft P, Lenters E, Bakker-Verweij M. de KM, Baylan U, Harteveld CL, Giordano PC. Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol 2009;31:484-95.
17. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 2000;108:295-9.
18. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 2000;95:360-2.
19. Tritipsombut J, Phylipsen M, Viprakasit V, Chalaow N, Sanchaisuriya K, Giordano PC, Fucharoen S, Harteveld CL. A single-tube multiplex gap-polymerase chain reaction for the detection of eight beta-globin gene cluster deletions common in Southeast Asia. Hemoglobin 2012;36:571-80.
20. Craig JE, Barnetson RA, Prior J, Raven JL, Thein SL. Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood 1994;83:1673-82.
21. Craig JE, Barnetson R, Weatherall DJ, Thein SL. Rapid detection of a 13.4-kb deletion causing delta beta thalassemia in an Egyptian family by polymerase chain reaction. Blood 1993;81:861-3.
22. Harteveld CL, Refaldi C, Cassinerio E, Cappellini MD, Giordano PC. Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients. Blood Cells Mol Dis 2008;40:312-6.
23. Sollaino MC, Paglietti ME, Perseu L, Giagu N, Loi D, Galanello R. Association of alpha globin gene quadruplication and heterozygous beta thalassemia in patients with thalassemia intermedia. Haematologica 2009; 94:1445-8.
24. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev 2003;17:43-53.
25. Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood 2001;98:250-1.
26. Old J, Harteveld CL, Traeger-Synodinos J, Petrou M, Angastiniotis M, Galanello R. Prevention of Thalassaemias and Other Haemoglobin Disorders. Laboratory Protocols, II 2nd edn. Nicosia, Cyprus: Thalassaemia International Federation; 2012.
27. Baysal E, Huisman TH. Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol 1994;46:208-13.
28. Phylipsen M, Chaibunruang A, Vogelaar IP, Balak JR, Schaap RA, Ariyurek Y, Fucharoen S, den Dunnen JT, Giordano PC, Bakker E, Harteveld CL. Fine-tiling array CGH to improve diagnostics for alpha- and beta-thalassemia rearrangements. Hum Mutat 2011;33:272-80.
29. Cremonesi L, Ferrari M, Giordano PC, Harteveld CL, Kleanthous M, Papasavva T, Patrinos GP, Traeger-Synodinos J. An overview of current microarray-based human globin gene mutation detection methods. Hemoglobin 2007;31:289-311.
30. Phylipsen M, Vogelaar IP, Schaap RA, Arkesteijn SG, Boxma GL, van Helden WC, Wildschut IC, de Bruin-Roest AC, Giordano PC, Harteveld CL. A new alpha(0)-thalassemia deletion found in a Dutch family (-(AW)). Blood Cells Mol Dis 2010;45:133-5.
31. Shalev H, Landau D, Pissard S, Krasnov T, Kapelushnik J, Gilad O, Broides A, Dgany O, Tamary H. A novel epsilon gamma delta beta thalassemia presenting with pregnancy complications and severe neonatal anemia. Eur J Haematol 2013;90:127-33.
32. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 1998;850:251-69.
33. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480-7.
34. Weatherall DJ. Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci 2010;1202:17-23.
35. Harteveld CL, Voskamp A, Phylipsen M, Akkermans N, den Dunnen JT, White SJ, Giordano PC. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet 2005;42:922-31.
36. Nooitgedagt JE, Harteveld CL, Starreveld JS, Versteegh FG, Giordano PC. A new deletion defect leading to alpha-thalassaemia in a large Dutch Caucasian family. Br J Haematol 2007;136:662-5.